KPC Pharmaceuticals,Inc. (SHA:600422)
China · Delayed Price · Currency is CNY 14.13
+0.06 (0.43%)
Sep 5, 2025, 2:45 PM CST
KPC Pharmaceuticals,Inc. Revenue
KPC Pharmaceuticals,Inc. had revenue of 1.74B CNY in the quarter ending June 30, 2025, a decrease of -6.68%. This brings the company's revenue in the last twelve months to 7.96B, down -5.87% year-over-year. In the year 2024, KPC Pharmaceuticals,Inc. had annual revenue of 8.40B, down -0.34%.
Revenue (ttm)
7.96B
Revenue Growth
-5.87%
P/S Ratio
1.35
Revenue / Employee
1.51M
Employees
5,275
Market Cap
10.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.40B | -28.73M | -0.34% |
| Dec 31, 2023 | 8.43B | 148.11M | 1.79% |
| Dec 31, 2022 | 8.28B | 28.53M | 0.35% |
| Dec 31, 2021 | 8.25B | 536.45M | 6.95% |
| Jan 1, 2021 | 7.72B | -402.88M | -4.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |